Page last updated: 2024-10-26

disopyramide and Diabetic Glomerulosclerosis

disopyramide has been researched along with Diabetic Glomerulosclerosis in 1 studies

Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.

Research Excerpts

ExcerptRelevanceReference
"Disopyramide (Norpace) is a widely used, generally well tolerated antiarrhythmic agent."5.27Hypoglycemic coma due to disopyramide toxicity. ( Gillman, MW; Stapleton, JT, 1983)
"Disopyramide (Norpace) is a widely used, generally well tolerated antiarrhythmic agent."1.27Hypoglycemic coma due to disopyramide toxicity. ( Gillman, MW; Stapleton, JT, 1983)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stapleton, JT1
Gillman, MW1

Other Studies

1 other study available for disopyramide and Diabetic Glomerulosclerosis

ArticleYear
Hypoglycemic coma due to disopyramide toxicity.
    Southern medical journal, 1983, Volume: 76, Issue:11

    Topics: Aged; Coma; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disopyramide; Humans; Hypoglycemia; M

1983